Disquisitions of Original Antigenic Sin. I. Evidence in man.
about
Saffold virus, a human Theiler's-like cardiovirus, is ubiquitous and causes infection early in lifeAn in-depth analysis of original antigenic sin in dengue virus infectionAntibodies with 'Original Antigenic Sin' Properties Are Valuable Components of Secondary Immune Responses to Influenza VirusesPotent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse modelAntigenic subversion: a novel mechanism of host immune evasion by Ebola virusEvidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infectionHeterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical TrialsCross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominanceImmunization with different PfAMA1 alleles in sequence induces clonal imprint humoral responses that are similar to responses induced by the same alleles as a vaccine cocktail in rabbitsH3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccinationUse of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussisEnhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.Immune history shapes specificity of pandemic H1N1 influenza antibody responses.Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virusResponses to A(H1N1)pdm09 influenza vaccines in participants previously vaccinated with seasonal influenza vaccine: a randomized, observer-blind, controlled study.Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.Lipopeptide vaccines illustrate the potential role of subtype-crossreactive T cells in the control of highly virulent influenzaDeep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza?Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu.Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccineExperimental infection with H1N1 European swine influenza virus protects pigs from an infection with the 2009 pandemic H1N1 human influenza virus.Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in EnglandAnalysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection.MF59 adjuvant: the best insurance against influenza strain diversity.Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus.A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients.Characterization of immune responses induced by immunization with the HA DNA vaccines of two antigenically distinctive H5N1 HPAIV isolatesInfluenza mortality in the United States, 2009 pandemic: burden, timing and age distribution.Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data.How does cross-reactive stimulation affect the longevity of CD8+ T cell memory?Influenza virus hemagglutinin-specific antibodies isolated from a combinatorial expression library are closely related to the immune response of the donor.Thrombocytopenia in Dengue: Interrelationship between Virus and the Imbalance between Coagulation and Fibrinolysis and Inflammatory Mediators.Influenza A gradual and epochal evolution: insights from simple models.Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo.Mechanisms of immune escape in viral hepatitis.
P2860
Q21131579-0AA7C33D-A0D1-4F96-8E7D-827F9D8F93F6Q24606493-F742E39D-4290-4C06-B850-835B57243B48Q27312311-1271EFD5-6FDF-48D4-B837-2B302EF305F7Q27330580-1C6C875D-7397-4683-B22F-FF14E28E0923Q27339643-62D13901-0E73-47FF-BF99-C2E3B19FB2FBQ27478105-631DC450-9CB6-49AF-A2BA-229AD6EAAAB2Q28394899-8B8CB7AA-9DAA-494B-AB15-84093F1395F4Q28728106-20D5F968-B79A-4332-AB41-D199C43FD1A5Q28742130-D6E419E1-BF54-4B90-8E7C-D7A592D08894Q28743596-232DE796-03D6-4F22-A79C-3CA9DD465859Q30275563-501B02F5-E104-4F8D-BDE7-1B138A8CB3CDQ30343761-0269E0DF-5219-453C-9A8C-A94250E240F2Q30352126-388D79F5-22B1-49AA-BB20-F3F5CBC6D942Q30352862-B2EDAB1C-D341-4632-94AA-9D563BB3FDE1Q30360439-4558BDFC-B76F-4C29-917B-1CB16EA1C93EQ30362883-2E653AAD-976A-4EBA-9C98-BFC910DFB0DBQ30375714-C2A11AC0-72EF-4133-89E1-7D00470DE0DDQ30376724-00E29565-3579-4576-BDCD-B6A5B11DB8D8Q30379213-42A49F15-2DD2-4B3E-8175-D14371BE5929Q30383252-936EFECA-58FF-4826-BDA6-C3118A9F52C2Q30384213-81D9B8E5-4F45-463F-B332-B6D96F6CDC18Q30385987-CF8A93B5-69A5-4288-9C52-B45034EB5DFAQ30388012-34F93CF4-4A6E-4F90-9582-EC103D931E61Q30388038-9454D346-F232-48EC-BFE6-03CE5C7D51E4Q30391898-C599C09F-4A95-440E-9DD7-B1C21644C4C6Q30397257-2B9E518E-1C5E-40C9-9128-6B131C36C92FQ30400179-37DC6764-D33A-4325-BDA6-FFA926A38F25Q30401866-D9C45FC0-1CBA-48CF-90DB-54A9FC1899FAQ30402018-4906E140-7D49-4CA4-AB0F-B3A0F4173AC6Q30407657-D5B36688-D71D-4100-85D9-0582458A59E0Q30413413-047C0EAF-6F47-45B3-B0E1-CE38C352D695Q30420017-835A7C37-0184-4175-AF2E-A99B2F5D87E3Q30431184-3C23E238-8E3A-41E9-A214-61A514DA8B86Q30903230-54FAB680-D2FE-4DA2-A308-83ACBF5D447DQ33247444-040CE8E2-2320-46FD-9D9E-61A98097031FQ33257211-4B34ECFD-0921-4033-877E-5FE9E8AA2652Q33423030-2E6A8DF0-B8E2-45F0-A13A-779678328312Q33511439-82E1C45D-B09C-4587-B687-24CB3F15A0CFQ33582453-2945432D-335E-422E-BD78-62D7C50D9152Q33594871-A9673D3D-55BC-4400-9489-D78CA791A682
P2860
Disquisitions of Original Antigenic Sin. I. Evidence in man.
description
1966 nî lūn-bûn
@nan
1966年の論文
@ja
1966年学术文章
@wuu
1966年学术文章
@zh-cn
1966年学术文章
@zh-hans
1966年学术文章
@zh-my
1966年学术文章
@zh-sg
1966年學術文章
@yue
1966年學術文章
@zh
1966年學術文章
@zh-hant
name
Disquisitions of Original Antigenic Sin. I. Evidence in man.
@ast
Disquisitions of Original Antigenic Sin. I. Evidence in man.
@en
type
label
Disquisitions of Original Antigenic Sin. I. Evidence in man.
@ast
Disquisitions of Original Antigenic Sin. I. Evidence in man.
@en
prefLabel
Disquisitions of Original Antigenic Sin. I. Evidence in man.
@ast
Disquisitions of Original Antigenic Sin. I. Evidence in man.
@en
P2860
P356
P1476
Disquisitions of Original Antigenic Sin. I. Evidence in man.
@en
P2093
Fazekas de St Groth
Webster RG
P2860
P304
P356
10.1084/JEM.124.3.331
P407
P577
1966-09-01T00:00:00Z